Search

everythinglearnresearchcommunity

for

Search:↓

Aging alone barely affects the number of hair follicles, meaning hair loss is minimal without other conditions like androgenetic alopecia.

Persistent radiation-induced hair loss is dose-dependent, and treatments like topical minoxidil can be effective.

People with alopecia areata have a higher risk of depression and anxiety, and often face unemployment and work absences.

Alopecia areata patients, especially women with nail issues or atopic diseases, are at higher risk for other autoimmune diseases.

Intralesional triamcinolone injections can effectively stop frontal fibrosing alopecia with minimal side effects.

Alopecia can be reversed with timely steroid treatment in VKH and SO diseases.

About 11% of patients with secondary syphilis had Syphilitic Alopecia, which usually improved with treatment.

Hair loss in children is often caused by scalp infections, immune disorders, hair pulling, stress, and requires careful treatment due to emotional effects.

Alopecia areata causes a significant economic burden in Japan, mainly due to productivity loss.

Hispanic/Latinx patients with alopecia areata often have it before age 40, with females and certain health conditions like rheumatoid arthritis more commonly affected.

The refined wash test is a reliable way to measure daily hair loss and can tell the difference between different types of hair loss.

Modified PRP therapy successfully treated severe alopecia unresponsive to traditional methods.

Autologous fat transfer improves hair growth in scarring alopecia and allows for denser hair transplants.

People with alopecia areata often have thyroid autoimmunity.

Researchers found genes linked to hair loss in male giant pandas.

The AI system HairComb accurately scores hair loss severity, matching dermatologist assessments.

Androgenetic alopecia can be treated with minoxidil and finasteride, requiring long-term use and patient cooperation.

Wigs help improve self-esteem and quality of life for people with hair loss from alopecia areata.

Most alopecia areata patients in the study were women, aged 15-49, with patchy hair loss and often had other health conditions.

The medicine baricitinib was found to notably improve hair regrowth in alopecia areata, but more research is needed on its side effects and other treatments.

Alopecia areata costs individuals about 3% of their income, with women, Asians, those with lower income, and more severe symptoms spending more.

Hair regrowth from severe alopecia areata treatment with baricitinib can vary, with faster results in those with shorter hair loss duration.

The letter suggests that the study's comparison group might have affected the results and calls for larger, more detailed future research.

The analysis found that alopecia areata, a hair loss condition, is not very common in Australia, affecting about 0.13% of people, with new cases most often seen in males aged 19 to 34 years.

Androgenetic alopecia is more common in Saudi men than women.

Different non-surgical treatments like minoxidil, microneedling, and laser therapy can slow down and even reverse common hair loss, but each has its own limitations.

Some dermatologists in Saudi Arabia prescribe Tofacitinib for hair loss, but many don't due to its unavailability and safety concerns.

The document discusses hair and nail conditions, updates on treatments for alopecia, and controversies around finasteride use.

848 genes related to fat and metabolism are less active in people with Central Centrifugal Cicatricial Alopecia.

The 16-year-old girl with hair loss was successfully treated for alopecia areata, leading to significant hair regrowth.